CG Invites Co., Ltd. (KOSDAQ:083790)
South Korea · Delayed Price · Currency is KRW 893.00
+38.00 (4.44%)
Jun 10, 2026, 3:30 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 68.67 billion as of June 10, 2026. Its market cap has decreased by -55.35% in one year.
Market Cap
68.67B
Enterprise Value
120.35B
Revenue
29.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
893.00
Market Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 68.67B, a decrease of -50.02%. That is a compound annual growth rate of -3.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 65.74B | -42.50% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 124.57B |
| Vaxcell-Bio Therapeutics | 119.08B |
| MedPacto | 107.11B |
| Amicogen | 92.65B |
| ENCell | 90.21B |
| GeneOne Life Science | 88.86B |
| iNtRON Biotechnology | 82.67B |
| Prestige BioPharma | 74.04B |